Andrea McMurphy, MD
Otolaryngology · Mobile, ALNPI 1679502421
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $6,044 of the $7,684 with a category attached, or 78.7%. Johnson & Johnson accounts for 80.0% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2024 at $7,485 and has fallen 99.5% since, to $38 in 2025.
Across 24 payments — averaging $320.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$6K
- Medical Device Business Services, Inc.$1K
- Optinose US, Inc.$112
- Stryker$65
- Sanofi$49
- Regeneron Healthcare Solutions, Inc.$45
What the payments were for
- Consulting fees$6,04479%
- Travel & lodging$1,17415%
- Food & beverage$4656%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 4 | $6,143 |
| Medical Device Business Services, Inc. | 7 | $1,270 |
| Optinose US, Inc. | 6 | $112 |
| Stryker | 3 | $65 |
| Sanofi | 2 | $49 |
| Regeneron Healthcare Solutions, Inc. | 2 | $45 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Harmonic$6,044
How this compares
$7,684 in reported general payments places this provider in the 85th percentile of 155 otolaryngology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 247 | $7,855 |
| Fluticasone Propionate | 379 | $6,883 |
| Levocetirizine Dihydrochloride | 459 | $5,472 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 43 | $5,452 |
| Fluocinolone Acetonide Oil | 63 | $3,099 |
| Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort | 32 | $1,755 |
| Methylprednisolone | 149 | $1,197 |
| Clarithromycin | 23 | $897 |
| Doxycycline Hyclate | 67 | $777 |
| Clotrimazole | 13 | $631 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 52 | $631 |
| Famotidine | 67 | $599 |
| Ciprofloxacin Hcl | 47 | $479 |
| Mupirocin | 57 | $413 |
| Ondansetron OdtOndansetron | 23 | $343 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Mobile
- Douglas HolmesMobile$3K
- Kacie OglesbyMobile$3K
- James HarrisonMobile$3K
- Mark GacekMobile$3K
- Alfred NeumannMobile$3K
- Christopher WeeksMobile$3K
- John DavisHoover$251K
- William McFeelyHuntsville$70K
- Michael SillersBirmingham$53K
- Justin TurnerBirmingham$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.